Assessment of the effectiveness and safety of bevacizumab-based therapies for recurrent primary brain tumors: a multicenter real-world study by the Turkish Oncology Group (TOG) - Top-Institutions - MDSpire

Assessment of the effectiveness and safety of bevacizumab-based therapies for recurrent primary brain tumors: a multicenter real-world study by the Turkish Oncology Group (TOG)

  • By

  • Zehra Sucuoğlu İşleyen

  • Şaban Seçmeler

  • Abdullah Sakin

  • Şener Cihan

  • Mehmet Beşiroğlu

  • Seda Kahraman

  • Melek Karakurt Eryılmaz

  • Esra Zeynelgil

  • Eda Çalışkan Yıldırım

  • Engin Kut

  • Nilay Şengül

  • Fatma Paksoy Türköz

  • Özkan Alan

  • Özlem Özkul

  • Selver Işık

  • Feride Yılmaz

  • Ahmet Gülmez

  • Sema Türker

  • Gökhan Karakaya

  • Meral Günaldı

  • Leyla Özer

  • Asude Aksoy

  • Fatih Karataş

  • Teoman Sakalar

  • Derya Demirtaş Esmer

  • Fatih Teker

  • Necla Demir

  • Özgecan Dülgar

  • Serdar Turhal

  • Hacı Mehmet Türk

  • Kayhan Ertürk

  • Emir Çelik

  • M. Mustafa Atcı

  • February 14, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Medical Oncology
    • Neurosurgery

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Medical Oncology

  • #3

    Dana-Farber Cancer Institute / Brigham and Women’s Hospital
    Dana-Farber Cancer Institute / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Neuro-oncology
    • Medical Oncology
    • Neurosurgery

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neuro-oncology
    • Neurosurgery
    • Medical Oncology

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neuro-oncology
    • Neurosurgery
    • Medical Oncology

Original Source(s)

Assessment of the effectiveness and safety of bevacizumab-based therapies for recurrent primary brain tumors: a multicenter real-world study by the Turkish Oncology Group (TOG)

  • by Zehra Sucuoğlu İşleyen, Şaban Seçmeler, Abdullah Sakin, Şener Cihan, Mehmet Beşiroğlu, Seda Kahraman, Melek Karakurt Eryılmaz, Esra Zeynelgil, Eda Çalışkan Yıldırım, Engin Kut, Nilay Şengül, Fatma Paksoy Türköz, Özkan Alan, Özlem Özkul, Selver Işık, Feride Yılmaz, Ahmet Gülmez, Sema Türker, Gökhan Karakaya, Meral Günaldı, Leyla Özer, Asude Aksoy, Fatih Karataş, Teoman Sakalar, Derya Demirtaş Esmer, Fatih Teker, Necla Demir, Özgecan Dülgar, Serdar Turhal, Hacı Mehmet Türk, Kayhan Ertürk, Emir Çelik, M. Mustafa Atcı

  • February 14, 2026

Related Content

Medical Oddities: Essential Oil, Deadly Consequences

A cabinet mix-up, a chatty heart, a violet catheter bag, stressed kids, and tea that won’t save the brain—just another week.

Reduced levels of lysyl oxidase in plasma extracellular vesicles: a potential biomarker associated with the risk of brain metastases in lung adenocarcinoma

Primary glioblastoma mimicking brain metastasis in ALK-positive lung adenocarcinoma: a case report and literature review